Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
LeMaitre Vascular Inc. (LMAT) is trading at $112.3 as of April 9, 2026, posting a minor 0.10% decline in the latest trading session. This analysis breaks down key technical levels, recent market context, and potential scenarios for the medical device stock in upcoming sessions. LMAT’s recent price action has been largely range-bound, with no major company-specific news driving sharp moves as of late, making technical levels a key point of focus for active traders monitoring the name. The stock o
Can LeMaitre Vascular (LMAT) Stock become a market leader | Price at $112.30, Down 0.10% - Target Price
LMAT - Stock Analysis
4182 Comments
1222 Likes
1
Tamelia
Experienced Member
2 hours ago
Missed the opportunity… sadly. 😞
👍 142
Reply
2
Pamelyn
Regular Reader
5 hours ago
Ah, I should’ve caught this earlier. 😩
👍 169
Reply
3
Darryn
Registered User
1 day ago
Free US stock industry life cycle analysis and market share trends to understand competitive dynamics and industry evolution over time. We analyze industry evolution and company positioning to identify sustainable winners and declining businesses in changing markets. We provide industry lifecycle analysis, market share tracking, and competitive dynamics for comprehensive coverage. Understand industry evolution with our comprehensive lifecycle analysis and market share tools for strategic positioning.
👍 31
Reply
4
Emric
Experienced Member
1 day ago
Every detail feels perfectly thought out.
👍 237
Reply
5
Mackston
Senior Contributor
2 days ago
I don’t know why, but this feels urgent.
👍 39
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.